NATCO PHARMA LIMITED. (INDIA)

Bortenat

Bortenat contains Drug / Molecule called “Bortezomib”. Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of proteasome. It prevents targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.

Details
Specification

Indication

Bortenat is used for the treatment of Multiple Myeloma. Also used for Mantle Cell Lymphoma

Note

Precaution

Bortenat is a prescription drug and should be used under proper medical guidance and advice.

Contraindicated in patients with hypersensitivity to Bortezomib, boron or mannitol.

Updated On Oct 15, 2019 by Admin

Strength

2 mg & 3.5 mg

Packing

Single Use Vial

Storage

store below 25 C and protect from moisture and light

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Bortenat also available as

Janssen-Cilag,

Velcade-bortenat

"Velcade" contains Drug / Molecule called “Bortezomib”.Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of proteasome. It prevents targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.

“Bortenat” is the generic version of "Velcade" and both contains same drug “Bortezomib”.